Myriad Genetics Inc (NASDAQ: MYGN) stock suffered a major decline of -14.8% on 2/25/25. The shares closed at $11.74. Moreover, this decline was accompanied by exceptionally high trading volume at 239% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -19.4% during the last week.
Current PriceTarget Research Rating
Myriad Genetics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Myriad Genetics has a poor Appreciation Score of 24 and a very low Power Rating of 9, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment